India's pharma, traditional-medicine sectors face slowdown

05/8/2013 | PharmaBiz.com (India)

The global economic downturn coupled with government austerity measures have slowed the growth of the Indian pharmaceutical industry as well as the Ayurvedic sector. New regulations imposed by the EU to combat the influx of counterfeit medicines have also slowed exports. The best prospects for growth in Indian pharmaceuticals include developing generics and biosimilars, strengthening drug-manufacturing capability, restructuring businesses to allow mergers and acquisitions, and keeping a sharp focus on global markets, say Indian drug-company officials.

View Full Article in:

PharmaBiz.com (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID